Clinical Trial Update: A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating AMD11070 in HIV-infected patients with X4-tropic virus has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• AMD11070

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: HIV Infections, X4 Tropic Virus | Phase 1 | Status: COMPLETED